Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;54 Suppl 4(Suppl 4):S245-9.
doi: 10.1093/cid/cis206.

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

M R Jordan  1 , D E Bennett, M A Wainberg, D Havlir, S Hammer, C Yang, L Morris, M Peeters, A M Wensing, N Parkin, J B Nachega, A Phillips, A De Luca, E Geng, A Calmy, E Raizes, P Sandstrom, C P Archibald, J Perriëns, C M McClure, S Y Hong, J H McMahon, N Dedes, D Sutherland, S Bertagnolio
Affiliations

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

M R Jordan et al. Clin Infect Dis. 2012 May.

Abstract

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Countries implementing 1 or more elements of the World Health Organization human immunodeficiency virus drug resistance prevention and assessment strategy, June 2011. This map is an approximation of actual country borders. Abbreviation: WHO, World Health Organization.
See this image and copyright information in PMC

References

    1. Joint United Nations Programme on HIV/AIDS (UNAIDS) AIDS at 30: nations at the crossroads. Geneva, Switzerland: UNAIDS; 2011. Available at: http://www.unaids.org/unaids_resources/aidsat30/aids-at-30.pdf. Accessed 23 December 2011.
    1. World Health Organization/UNAIDS. The treatment 2.0 framework for action: catalysing the next phase of treatment, care, and support. Available at: http://data.unaids.org/pub/Outlook/2010/20100713_outlook_treatment2_0_en.... Accessed 15 December 2011.
    1. Mills EJ, Nachega JB. A wake-up call for global access to salvage HIV drug regimens. Lancet. 2007;370:1885–7. - PubMed
    1. Wainberg MA, Zaharatos GJ, Brenner BG. Development of antiretroviral drug resistance. N Engl J Med. 2011;365:637–46. - PubMed
    1. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385–94. - PubMed

Publication types

Substances